Synapse Medicine

Bordeaux, France Founded: 2017 • Age: 9 yrs
Virtual assistant for drug prescriptions is provided to healthcare professionals.

About Synapse Medicine

Synapse Medicine is a Technology company based in Bordeaux (France) founded in 2017. Virtual assistant for drug prescriptions is provided to healthcare professionals. It operates in the Technology and Healthcare sectors. Synapse Medicine has raised $38.81 million across 3 funding rounds from investors including BNP Paribas, Bpifrance and Korelya Capital. Its chief executive, as recorded, is Clement Goehrs. Its website synapse-medicine.com draws about 24 thousand monthly visits. Synapse Medicine offers products and services including Drug Information Monographs, Patient Clinical Profile, Allergy Search, Drug Interactions Analysis, and Order Entry. Its focus areas include HealthTech, Disease Self Management, Medication Adherence and App.

Company details

Synapse Medicine was founded in 2017 in Bordeaux, France, within the health technology sector. A virtual assistant for drug prescription is offered through the platform, along with information on medical errors. These resources are delivered to healthcare professionals, telemedicine companies, hospitals, and other facilities to support clinical decision-making and error prevention across operations.

Key Metrics
  • Total Equity Funding
    $38.81M (USD)

    in 3 rounds

  • Latest Funding Round
    $27.98M (USD), Series B

    Mar 2022

  • Investors

Products & Services of Synapse Medicine

Synapse Medicine offers a comprehensive portfolio of products and services, including Drug Information Monographs, Patient Clinical Profile, Allergy Search, Drug Interactions Analysis, and Order Entry.

Drug Information Monographs
Information Tool

Provides medication suggestions as user types.

Patient Clinical Profile
Patient Management

Enables personalized prescriptions based on clinical conditions.

Allergy Search
Search Tool

Allows quick input of drug allergies through autocomplete.

Drug Interactions Analysis
Analysis Tool

Detects interactions and contraindications for safer prescribing.

Order Entry
Prescribing Tool

Facilitates entering dosing specifics for medications.

Apps and channels of Synapse Medicine

Synapse Medicine publishes 1 mobile app; its YouTube channel Synapse Medicine has 334 subscribers and 30 videos.

Goodmed - Scan de médicaments
App Store Medical 17+
Developer: Synapse Medicine
View on App Store
Synapse Medicine
YouTube 334 subscribers 30 videos Science & Technology
Open channel

Videos from Synapse Medicine

The most watched videos on Synapse Medicine's YouTube channel, Synapse Medicine (334 subscribers). Click a video to play it here.

La pharmacovigilance, qu'est-ce que c'est ? 💊
7.3K views
Synapse Copilote : Le nouveau standard de l’aide à la décision médicale par l’IA
920 views
Copilote Follow : Révolutionner le suivi patient avec l'IA
598 views
Synapse Medicine - Dr. Clement Goehrs, Co-founder & CEO
595 views

More on Synapse Medicine.

Funding Insights of Synapse Medicine

Synapse Medicine has successfully raised a total of $38.81M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $27.98 million completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $38.81M
  • Total Rounds 3
  • Last Round Series B — $27.98M
  • First Round $2.83M

    (Mar 2019)

  • Investors Count 8

All 3 funding rounds of Synapse Medicine with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2022$27.98MSeries B–Korelya Capital
Jul 2020$8MSeries A–MACSF
Mar 2019$2.83MSeed–XAnge
Valuation history

8 investors in total: 7 institutional and 1 angel.

Investors in Synapse Medicine

Synapse Medicine has secured backing from 8 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include BNP Paribas, Bpifrance and Korelya Capital.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Venture capital firm focused on investing in tech startups
korelyacapital.comParis, France
Venture capital fund focused on tech companies
xange.vcParis, France
Venture capital is provided to French companies by the firm.
bnpparibasdeveloppement.comParis, France
Seed-stage investments in startups are provided by Kima Ventures.
kimaventures.comParis, France
Provides mutual health, property, casualty, and pension insurance services.
2005macsf.frLa Defense, France
Corporate consultancy, advisory, and funding services are provided to businesses.
2012bpifrance.comMaisons Alfort, France
Banking & financial service provider
1848group.bnpparibasParis, France

Nicolas Dessaigne

Co-founder of Algolia, active angel investor in tech startups
unknown_2d7ff71968334bb2b
Premium access

Investor details for Synapse Medicine

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Synapse Medicine

38 people are tracked at Synapse Medicine (13 in leadership, 25 in team).

NameRoleGroup
Clement Goehrs
CEOLeadership
Elisa Daviaud
Head Of DesignLeadership
Fanny Matharan
Director User ExperienceLeadership
Alicia Bel-Létoile
Co-Founder & CTOLeadership
Louis Létinier
Medical Director & co-founderLeadership
Mathilde Terral
Head Of MedicalLeadership
Nadjib B.
Head of MarketingLeadership
Rebecca McKenney
Vice President Business OperationsLeadership
Julien Jouganous
Head Of Artificial IntelligenceLeadership
Clémentine Espinasse
Head Of ProductsLeadership
Eric Chollet
Head Of ProductsLeadership
Cléa Didolla
Head Of FinanceLeadership
Damien Spennato
Head Of PeopleLeadership
Léonore Bordenave
UX ResearcherTeam
Carole Baudry
Senior UX ResearcherTeam
Hélène Boersma
Data EngineerTeam
Elodie Comte-Trotet
Event Marketing ManagerTeam
Hanna Schmidt Mumm
Marketing Project ManagerTeam
Raquel Mercado Calva
Développeur webTeam
Clovis Portron
Responsable Équipe TechniqueTeam

18 more people are available in the full profile.

Premium access

Complete people profiles for Synapse Medicine

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Synapse Medicine

3 dated milestones of Synapse Medicine across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Synapse Medicine is founded.
  2. Funding First funding round of $2.8M.
  3. Funding Latest funding round, Series B, of $28.0M.

Web traffic of Synapse Medicine

The website of Synapse Medicine (synapse-medicine.com) receives about 24.3K visits a month.

  • Monthly visits
    24.3K

    ▼ 10.8% vs previous month

Similar websites

Websites whose visitors overlap most with Synapse Medicine. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
bimedoc.com
100%
4.6K#2,260,916View details
maincare.com
98%
32.1K#779,872View details
tentelemed.com
91%
#2,153,977View details
quellepharmacie.fr
quellepharmacie.fr
85%
#3,084,246–
atoopharm.fr
atoopharm.fr
68%
#8,551,030–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 11 similar websites and full traffic analytics for Synapse Medicine

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 11 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Synapse Medicine

Premium access

Complete news archive for Synapse Medicine

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Synapse Medicine

Synapse Medicine was founded in 2017 and raised its 1st funding round 2 years after it was founded.

Synapse Medicine is headquartered in Bordeaux, France.

Clement Goehrs is the CEO of Synapse Medicine, as recorded in our data.

Synapse Medicine is a funded company, having raised a total of $38.81M across 3 funding rounds to date. The company's 1st funding round was a Seed of $2.83M, raised on Mar 2019.

Synapse Medicine was founded in 2017 in Bordeaux, France, within the health technology sector. A virtual assistant for drug prescription is offered through the platform, along with information on medical errors. These resources are delivered to healthcare professionals, telemedicine companies, hospitals, and other facilities to support clinical decision-making and error prevention across operations.

Synapse Medicine offers Drug Information Monographs, Patient Clinical Profile, Allergy Search, Drug Interactions Analysis, and Order Entry.

Synapse Medicine has 8 investors. Key investors include BNP Paribas, Bpifrance, Korelya Capital, XAnge, and MACSF.

Yes. Synapse Medicine publishes Goodmed - Scan de médicaments.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available